Bio Impact Capital LLC Aquestive Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $641 Million
- Q3 2024
A detailed history of Bio Impact Capital LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 1,796,750 shares of AQST stock, worth $8.57 Million. This represents 1.4% of its overall portfolio holdings.
Number of Shares
1,796,750Holding current value
$8.57 Million% of portfolio
1.4%Shares
1 transactions
Others Institutions Holding AQST
# of Institutions
115Shares Held
46MCall Options Held
271KPut Options Held
212K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$46.8 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$26.5 Million1.58% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$26 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.26MShares$20.3 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.77MShares$13.2 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $254M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...